This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pacific Biosciences of California Inc (PACB)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 26.36M 46.54M 58.86M 147.65M
Receivables 2.75M 2.82M 4.56M 341.00K
Inventories 10.05M 9.59M 15.52M 6.86M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 126.46M 115.00M 199.60M 293.11M
Property, Plant & Equipment, Gross 35.48M 35.09M 33.57M 24.84M
Accumulated Depreciation & Depletion 26.25M 20.76M 15.17M 12.53M
Property, Plant & Equipment, Net 9.24M 14.33M 18.40M 12.31M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 490.00K 354.00K 317.00K 322.00K
Total Non-Current Assets 9.73M 14.68M 18.72M 12.63M
Liabilities & Shareholder Equity
Total Assets 136.18M 129.68M 218.32M 305.75M
Accounts Payable 1.72M 2.99M 4.74M 9.52M
Short Term Debt 210.00K 173.00K 140.00K 110.00K
Other Current Liabilities 10.83M 0.00 0.00 0.00
Total Current Liabilities 22.56M 14.74M 19.38M 20.84M
Long Term Debt 13.35M 0.00 0.00 2.93M
Deferred Income Taxes 27.04M 0.00 0.00 0.00
Other Non-Current Liabilities 1.66M 2.94M 4.69M 2.11M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 44.45M 5.56M 7.48M 5.04M
Total Liabilities 67.00M 20.30M 26.85M 25.88M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 69.18M 109.38M 191.46M 279.87M
Common Par 66.00K 56.00K 55.00K 53.00K
Additional Paid In Capital 684.41M 645.32M 632.91M 612.00M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -615.31M -536.02M -441.56M -332.17M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 14.00K 30.00K 57.00K -21.00K
Total Capitalization 82.53M 109.38M 191.46M 282.79M
Total Equity 69.18M 109.38M 191.46M 279.87M
Total Liabilities & Stock Equity 136.18M 129.68M 218.32M 305.75M
Total Common Shares Outstanding 66.28M 56.17M 54.96M 52.86M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 62.78M 55.73M 53.87M 9.94M
Diluted Weighted Shares Outstanding 62.78M 55.73M 53.87M 9.94M
Number of Employees 318 342 431 431
Number of Part-Time Employees 0 0 0 0
PACB News

PACB Pacific Biosciences of California Inc

Analysts Ratings for PACB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PACB ANALYST REPORT

Brokerage Partners

PACB Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs